Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qudexy XR for Migraine Prevention in Children
NCT04748601Phase 4Recruiting
- Sponsor
- Upsher-Smith Laboratories
- Start
- Feb 2021
- Primary completion
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of topiramate in migraine, sponsored by Upsher-Smith Laboratories. Started Feb 2021; status: recruiting.
02
Drugs
topiramate
03
Conditions
migraine
Beyond the preview
Go deeper on NCT04748601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748601.